Lucerno Dynamics

LucernoInitial Investment: September 2015
Lead Partner:John Cambier

Lucerno provides oncologists a quantitative assessment of tumor response to treatment; thus, identifying effective therapy, improving patient outcomes and dramatically reducing costs. Lucerno also has potential to aid oncologists in initial treatment selection and speed oncology drug development.

 

Lucerno in the news


Lucerno launches massive PET/CT sensor study

MORRISVILLE, N.C. — Lucerno Dynamics, a Morrisville company developing noninvasive sensor technology that can show the effectiveness of radiotracer injections in patients undergoing PET/CT scans, has launched a nationwide study to demonstrate the benefits of its system. The study, called “Lara-Q1,” is to enroll more than 10,000 patients in up to a dozen sites around …

Posted in Lucerno | Comments Off on Lucerno launches massive PET/CT sensor study

Lucerno’s next step for commercial device after $6M funder

Lucerno Dynamics – which recently completed its series A equity funding round, raising $6.34 million – has a commercially available device and has launched a new study with it. The Morrisville-based company’s Class 1 device, the Lara System, is now listed with the U.S. Food and Drug Administration. The device detects and monitors infiltrations of …

Posted in Lucerno | Comments Off on Lucerno’s next step for commercial device after $6M funder

Lucerno Dynamics Secures $6.34M to Commercialize First Application of Sensor Technology

Morrisville, NC – October 10, 2016 – Lucerno Dynamics, LLC, a medical device start-up in Morrisville, NC, announces the completion of its series A equity funding round with a total $6.34 million raised. “We are very pleased with the response to our fundraising campaign,” said Ron Lattanze, Lucerno’s chief executive officer. “This completes our funding …

Posted in Lucerno | Comments Off on Lucerno Dynamics Secures $6.34M to Commercialize First Application of Sensor Technology